Expert Speakers Confirmed for the 29th Great Wall International Cardiology Conference (GW-ICC)

May 2018: The GW-ICC board are delighted to announce the expert speakers for China’s premier cardiology congress. The 29th Great Wall International Cardiology Conference (GW-ICC) takes place from October 11-14, 2018 in Beijing, China.

The conference is jointly organized by more than 20 domestic and international cardiovascular academic organizations and will include 13 academic fields, 18 kinds of sessions, nearly 60 professional categories, more than 400 academic exchange activities, seminars, training workshops, exhibitions and joint forums run with nearly 20 well-known international academic organizations. It is expected that the conference will welcome more than 1,000 scholars from nearly 40 countries and regions, more than 2,000 experts across China and over 18,000 guests and representatives, who will share and learn the latest progress, knowledge and innovation in cardiology and related fields.

Notable speakers will include:

C. Michael Valentine, MD, FACC, ACC President

Dr. Valentine is a senior cardiologist at the Stroobants Cardiovascular Center of Centra Health in Lynchburg, Virginia, USA and has previously served on the ACC’s board of trustees and advocacy committee and as the Virginia chapter governor and board of governors’ chair. He graduated from the University of Virginia School of Medicine. Dr. Valentine has special training and interest in pacing, electrophysiology and interventional cardiology.

Barbara Casadei, MD DPhil FRCP FMedSci FESC, President Elect of the European Society of Cardiology

Professor Casadei is currently Deputy Head of Division of Cardiovascular Medicine in Oxford. Professor Casadei provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme focussed on atrial fibrillation, which spans from clinical trials to bench-based investigation in human tissue and cells.

Ivor J. Benjamin, MD, FACC, FAHA, President Elect of the AHA

Dr. Ivor J. Benjamin, is currently professor of medicine and director of the Cardiovascular Center at Froedtert Hospital and the Medical College of Wisconsin, USA. Dr Benjamin received his medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years.

David Wood, MB ChB, MSc, FRCP, FRCPE, FFPHM, FESC, President World Heart Federation

Professor Wood is currently Garfield Weston Professor of Cardiovascular Medicine and Honorary Consultant Cardiologist, National Heart and Lung Institute, Imperial College London, United Kingdom. Professor Wood has contributed to international policy and guidelines on cardiovascular disease (CVD) prevention through the World Health Organization, World Heart Federation and the European Society of Cardiology. He was a founder and President of the European Association for Cardiovascular Prevention and Rehabilitation and a Board member of the European Society of Cardiology.

Valentin Fuster, MD, PhD, Editor-in-Chief of Journal of the American College of Cardiology

After qualifying in medicine at the University of Barcelona, Dr Fuster continued his studies in the United States. Currently he serves The Mount Sinai Medical Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health and is CEO of the National Center for Cardiovascular Research (CNIC). He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai. Dr Fuster has made significant contributions throughout his professional career to the advancement of cardiology research, the prevention and treatment of cardiovascular disease, particularly coronary artery disease, atherosclerosis and thrombosis.

Joseph Hill, MD, PhD, Editor-in-Chief of Circulation

Dr Joseph Hill is Chief of UT Southwestern Medical Center’s Division of Cardiology and Director of the Harry S. Moss Heart Center, Dallas, TX, USA. Dr Hill’s research focuses on molecular mechanisms of structural, functional, and electrophysiological remodeling in cardiac hypertrophy and heart failure. He earned his medical and doctoral (pharmacology) degrees at Duke University, completed fellowships with the Institut Pasteur in Paris and the Brigham and Women’s Hospital, Harvard Medical School.

Thomas F. Lüscher, MD, FRCP, Editor-in-Chief of European Heart Journal

Professor Thomas F. Lüscher is the Director of Research, Education & Development and Consultant of Cardiology at Royal Brompton & Harefield Hospital Trust and Imperial College, London, United Kingdom and Director of the Center for Molecular Cardiology at the University Zurich, Switzerland. Professor Lüscher is a board certified internist and cardiologist with training in internal medicine at the University Hospital Zurich, cardiovascular physiology and cardiology at the Mayo Clinic, Rochester, MN, USA and in cardiology and clinical pharmacology at the University Hospital Basel, Switzerland. Prior to his current position he was Professor of Pharmacotherapy at the University of Basel, then Professor and vice-chairman of cardiology at the Inselspital of the University of Berne, Switzerland.

More information is available at http://en.gw-icc2017.org/en/jsp/login.jsp